SHP099  ≥98%

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:5mg 25mg 100mg in glass bottle
产品简介:一种有效的选择性的有口服活性的SHP2抑制剂,IC50:70 n。 SHP099 is a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor with IC50 =0.07 μ and p-ER odulation in cells IC50 = 0.250 μ. SHP099 exhibits dose-dependent pathway inhibition and antituor activity in xenograft odels. SHP2 is a nonreceptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene involved in cell growth and differentiation via the AP signaling pathway. SHP2 also purportedly plays an iportant role in the prograed cell death pathway (PD-1/PD-L1).
溶解性:DMSO:12 mg/mL (34.07 mM; 超声助溶) Water:< 0.1 mg/mL (insoluble)
产品描述:一种有效的选择性的有口服活性的SHP2抑制剂,IC50:70 n。SHP099 is a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor with IC50 =0.07 μ and p-ER odulation in cells IC50 = 0.250 μ. SHP099 exhibits dose-dependent pathway inhibition and antituor activity in xenograft odels. SHP2 is a nonreceptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene involved in cell growth and differentiation via the AP signaling pathway. SHP2 also purportedly plays an iportant role in the prograed cell death pathway (PD-1/PD-L1).
保存条件:-20℃